The CARDIOPROTECT Trial

Clinical trial NCT07654426 · RECRUITING

Trial details

NCT number: NCT07654426
Sponsor: Beth Israel Deaconess Medical Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Large B-cell Lymphoma (DLBCL)Cardiotoxicity Lymphoma

Start date: 2026-08-31
Primary completion: 2030-12-31
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.